Daily Bulletin (26th August, 2022)
https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220826-46
Scrip code : 543245
Name : Gland Pharma Limited
Subject : US FDA Inspection US FDA Inspection.
Scrip code : 500410
Name : ACC Ltd
Subject : Updates on Open Offer
ICICI Securities Ltd & Deutsche Equities India Pvt Ltd (“Managers to the Offer”) has submitted to BSE a copy of Disclosure of the number of Equity Shares tendered in connection with the open offer to the Public Shareholders of ACC Ltd (“Open Offer”).
Scrip code : 512599
Name : Adani Enterprises Ltd.
Subject : Update On Our Public Announcement Dated August 23, 2022
In Relation To The Open Offer (‘Open Offer’) For Fully Paid-Up Equity Shares Of Face Value Of Rs.4 Each Of New Delhi Television Limited (‘NDTV’), Under The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 Update on our Public Announcement dated August 23, 2022 in relation to the open offer (‘Open Offer’) for fully paid-up equity shares of face value of Rs.4 each of New Delhi Television Limited (‘NDTV’), under the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Scrip code : 512599
Name : Adani Enterprises Ltd.
Subject : Update On Exercise Of Certain Warrants Held By Vishvapradhan Commercial Private Limited (‘VCPL’), An Indirect Subsidiary Of Adani Enterprises Limited (‘Company’) For Acquiring 99.50% Of The Equity Share Capital Of RRPR Holding Private Limited (‘RRPR’), A Promoter Company Of New Delhi Television Limited (‘NDTV’)
Update on exercise of certain warrants held by Vishvapradhan Commercial Private Limited (‘VCPL’), an indirect subsidiary of Adani Enterprises Limited (‘Company’) for acquiring 99.50% of the equity share capital of RRPR Holding Private Limited (‘RRPR’), a promoter company of New Delhi Television Limited (‘NDTV’).
Scrip code : 500425
Name : Ambuja Cements Ltd.
Subject : Updates on Open Offer
ICICI Securities Ltd & Deutsche Equities India Pvt Ltd (“Managers to the Offer”) has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, and Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders of Ambuja Cements Ltd (“Target Company”).
Scrip code : 512091
Name : Anshuni Commercials Ltd.,
Subject : Corporate Action-Board recommends Bonus Issue
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 this is hereby to inform you that the Board of Directors of the Company at its meeting held on 26th August, 2022 has duly considered the following: a) Approved the Alteration of Memorandum of Association (MoA) of the company subject to approval by the shareholders in the General Meeting. b) Approved the Proposal of Adoption of new sets of Articles of Association (AoA) of the company containing regulations in conformity with the Companies Act, 2013, subject to approval by the shareholders in the General Meeting. c) Increase in Authorised Share Capital of the Company, subject to approval of the shareholders in the General Meeting. d) Issue of (4) four bonus equity shares of face value of Rs. 10/- (Rupees Ten only) for every 1 (one) fully paid-up equity share of Rs. 10/- (Rupees Ten only).
Scrip code : 531739
Name : Gennex Laboratories Ltd
Subject : Announcement under Regulation 30 (LODR)-Allotment
With reference to captioned subject and in furtherance of Rights Issue of the Company, this is to inform that in terms of the Letter of Offer dated July 16, 2022 and in accordance with the Basis of Allotment finalized in consultation with BSE Limited (Designated Stock Exchange), the Lead Manager to the Issue and the Registrar to the Issue, the Rights Issue Committee of the Company has, at its meeting held on today, i.e., August 26, 2022, approved the allotment of 5,25,06,534 Rights Equity Shares of face value of Rs.1/- each (Rs.0.25/- paid-up) at a price of Rs.6/- per Rights Equity Share including a share premium of Rs.5/- per Rights Equity Share, of which Rs.1.50/- per Rights Equity Share including a share premium of Rs.1.25/- per Rights Equity Share has been paid up on application and the balance amount shall be payable on First and Final Call at such time as may be determined by the Board at its sole discretion.
Scrip code : 532482
Name : Granules India Ltd.
Subject : Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited Received ANDA Approval for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets.
Scrip code : 542830
Name : Indian Railway Catering & Tourism Corporation Ltd
Subject : News Article Appearing In Www.Thehindubusinessline.Com Dated 18Th August 2022 Captioned ‘IRCTC Floats Tender For Appointing Consultant For Digital Data Monetization’
In reference to the above mentioned communication, it is to further inform that due to withdrawal of Personal Data Protection Bill 2018 by the Government of India, the above referred E-tender for appointment of Consultant for Data Monetization of Indian Railway/ IRCTC floated by IRCTC, on 29th July, 2022 has been withdrawn. This is for your kind information and record.
Scrip code : 543277
Name : Laxmi Organic Industries Limited
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
This is to inform you that the Hon”ble National Company Law Tribunal (”NCLT”), Mumbai Bench, vide hearing convened on August 25, 2022, has sanctioned the Scheme of Merger by Absorption of Acetyls Holdings Private Limited and Yellowstone Chemicals Private Limited (‘Transferor Companies’ with Laxmi Organic Industries Limited (‘Transferee Company’) under Section 230 to Section 232 of the Companies Act, 2013. The certified copy of the Order from NCLT, Mumbai Bench is awaited. The Scheme will be made effective upon filing of the certified copy of the Order with the Registrar of Companies. This disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records.
Scrip code : 532555
Name : NTPC Limited
Subject : Corporate Disclosure – Investment Approval For Talcher Thermal Power Project, Stage-III (2X660 MW)
We wish to inform that the Board of Directors of the Company has accorded investment approval for Talcher Thermal Power Project, Stage-III (2×660 MW) at an appraised current estimated cost of Rs. 11,843.75 crore.
Scrip code : 532891
Name : Puravankara Limited
Subject : Announcement under Regulation 30 (LODR)-Raising of Funds
We wish to inform you that the following was the outcome of the Board Meeting of Puravankara Limited held today: 1. Approval of the issue of fully Secured, Unlisted, Redeemable, Cumulative, Non-Convertible Series II Debentures (‘Series II Debentures’) via private placement and matters related thereto. 2. Approval of the issue of fully secured, unlisted, redeemable, cumulative, non-convertible Series III Debentures (‘Series III Debentures’) via private placement and matters related thereto.
Scrip code : 510245
Name : Swasti Vinayaka Synthetics Ltd.,
Subject : Announcement under Regulation 30 (LODR)-Preferential Issue
Raising of funds by issuance of 8040 equity shares of face value of Rs. 1/- each to Swasti Vinayaka Realestate Development Private Limited, Promoter Group Company, on a preferential basis (“Preferential Issue”) in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”), as amended from time to time; and the provisions of the Companies Act, 2013 and rules made thereunder, at a price not being lower than the price determined in accordance with Chapter V of SEBI ICDR Regulations and other applicable regulation, if any subject to approval of the shareholders of the Company. Details pursuant to Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 are enclosed as Annexure I.